Healthy Aging in People With Epilepsy Program
HAP-E
1 other identifier
interventional
90
1 country
1
Brief Summary
The goal of this clinical trial is to develop and test an educational program about dementia in older adults living with epilepsy. The main questions it aims to answer are:
- Complete a 12-week group educational program.
- Complete pre- and post-program evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
September 25, 2023
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2029
September 25, 2023
September 1, 2023
2.9 years
September 18, 2023
September 18, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Dementia Knowledge
Dementia Knowledge Assessment Tool was designed to measure change in knowledge of dementia including dementia and its progress, support, and care. It contains 21 true/false items.
Pre and Post intervention (3 months)
Health literacy
Short Assessment of Health Literacy-English is an 18-item scale assessing adult's ability to read and understand common medical terms.
Pre and Post intervention (3 months)
Health Related Quality of life
Quality of life in Epilepsy-31 is a self-report questionnaire assessing quality of life in individuals with epilepsy. It measures of overall quality of life, emotional well-being, role limitations due to emotional problems, social support, social isolation, energy/fatigue, worry about seizure, medication effects, health discouragement, work/driving/social function, physical function, pain, role limitations due to physical problems, health perception, and perceived problems with attention/concentration, language, memory.
Pre and Post intervention (3 months)
Study Arms (1)
HAP-E Epilepsy Participants
EXPERIMENTALInterventions
This a 12-week group educational program providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors.
Eligibility Criteria
You may qualify if:
- Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
- Proficiency in English
You may not qualify if:
- Dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Califonia, San Diego
San Diego, California, 92093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Fellow
Study Record Dates
First Submitted
September 18, 2023
First Posted
September 25, 2023
Study Start
August 1, 2024
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
June 1, 2029
Last Updated
September 25, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share